Lorundrostat cut systolic BP by 9.6 mm Hg and UACR by 52.2% vs placebo in participants with CKD and uncontrolled hypertension in Launch-HTN.
|Videos|August 9, 2016
Misty Humphries from UC Davis: Diagnosing Peripheral Artery Disease Early Key in Limb Salvation
Author(s)Adam Hochron
Diagnosing peripheral artery disease can be a simple process if doctors know what they are looking for and patients follow medical directions.
Advertisement
Diagnosing peripheral artery disease (PAD) can be a simple process if doctors know what they are looking for and patients follow medical directions.
Working at the UC Davis Vascular Center, Misty D. Humphries, MD, MAS, RPVI, said a considerable amount of their efforts are focused on treating this condition. By the time many of their patients have reached the center Humphries said critical limb ischemia is a difficult challenge to tackle. Humphries called it the "extreme" end of the spectrum for PAD.
Advertisement
Related to this article
The ENRICH-AF trial ultimately did not demonstrate edoxaban’s efficacy, highlighting the need for further stroke prevention strategies for this patient population.
A recent MRI analysis of the pivotal OCEANIC-STROKE trial has indicated a complete lack of association between infarct patterns and asundexian’s efficacy.
A new analysis of 4 major trials has revealed the association between lower SBP and higher TTR and the risk of recurrent stroke after intracerebral hemorrhage.
Data from the phase 2a BIRCH trial demonstrated the treatment’s improvements in mRS and NLR, positioning it for a late-phase trial in the future.
A new analysis of the BRIDGE-TNK trial has demonstrated that patients with cardioembolism are more likely to derive benefit than those with large artery atherosclerosis.
Edaravone dexborneol before thrombectomy improved 90-day independence only in LVO stroke patients with clinical-radiological mismatch in TASTE-2.
Alia Galadari, MD, discusses subtle erythema, commonly missed diagnoses, and research gaps to help clinicians recalibrate their approach to skin of color.
Advertisement
Advertisement
Trending on HCPLive
1
eGFR Underestimates CKD in Patients with Cancer, Study Finds
2
The HCPFive: Top News for Healthcare Providers from the Week of 10/18
3
42% on Povetacicept Reach KDIGO-Aligned UPCR Target in RAINIER
4
Kidney Compass: Final 2-Year TELIGAN Data for Telitacicept in IgA Nephropathy
5